Next-generation Sequencing Data Analysis Market (By Product: Services, NGS Commercial Software; By Workflow: Primary, Secondary, Tertiary; By Mode: In-house, Outsourced; By Read Length: Short Read Sequencing, Long Read Sequencing, Very Long Read Sequencing; By End-use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma& Biotech Entities, Other Users) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Next-generation Sequencing Data Analysis Market, By Product

7.1.  Next-generation Sequencing Data Analysis Market, by Product, 2021-2030

7.1.1.    Services

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    NGS Commercial Software

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Next-generation Sequencing Data Analysis Market, By Workflow

8.1.  Next-generation Sequencing Data Analysis Market, by Workflow, 2021-2030

8.1.1.    Primary

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Secondary

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Tertiary

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Next-generation Sequencing Data Analysis Market, By Mode

9.1.  Next-generation Sequencing Data Analysis Market, by Mode, 2021-2030

9.1.1.    In-house

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Outsourced

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Next-generation Sequencing Data Analysis Market, By Read Length

10.1.        Next-generation Sequencing Data Analysis Market, by Read Length, 2021-2030

10.1.1.  Short Read Sequencing

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Long Read Sequencing

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Very Long Read Sequencing

10.1.3.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Next-generation Sequencing Data Analysis Market, By End-use

11.1.        Next-generation Sequencing Data Analysis Market, by End-use, 2021-2030

11.1.1.  Academic Research

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  Clinical Research

11.1.2.1.      Market Revenue and Forecast (2017-2030)

11.1.3.  Hospitals & Clinics

11.1.3.1.      Market Revenue and Forecast (2017-2030)

11.1.4.  Pharma& Biotech Entities

11.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Next-generation Sequencing Data Analysis  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Product (2017-2030)

12.1.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.1.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.1.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.1.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.1.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.1.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.1.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.1.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.1.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.1.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.1.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Product (2017-2030)

12.2.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.2.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.2.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.2.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.8.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.8.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.9.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.9.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.9.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Product (2017-2030)

12.3.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.3.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.3.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.3.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.8.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.8.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.9.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.9.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.9.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Product (2017-2030)

12.4.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.4.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.4.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.4.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.8.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.8.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.9.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.9.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.9.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Product (2017-2030)

12.5.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.5.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.5.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.5.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.5.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.5.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.5.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.5.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.5.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.5.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.5.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 13.  Company Profiles

13.1.              Thermo Fisher Scientific, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              QIAGEN

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Illumina, Inc.

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              F. Hoffmann-La Roche Ltd.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Agilent Technologies, Inc.

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Bio-Rad Laboratories, Inc.

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              PierianDx

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Precigen Bioinformatics Germany GmbH

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Partek Incorporated

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Eurofins Scientific

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms